bosentan anhydrous has been researched along with Heart Septal Defects, Ventricular in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akbal, ÖY; Kaymaz, C; Öztürk, S; Poci, N; Tokgöz, HC | 1 |
| Cingoz, F; Kurkluoglu, M; Sahin, MA; Tavlasoglu, M | 1 |
| Hu, L; Tan, LH; Ye, J | 1 |
| Yao, A | 1 |
| Benson, L; Collins, NJ; Horlick, E | 1 |
| Beghetti, M; Berger, RM; Chiossi, E; Galiè, N; Gatzoulis, MA; Granton, J; Landzberg, M; Lauer, A | 1 |
| Gatzoulis, MA | 1 |
| Daniels, CJ | 1 |
| Matsumura, M; Nemoto, S; Nishimura, K; Yoshimura, S | 1 |
1 trial(s) available for bosentan anhydrous and Heart Septal Defects, Ventricular
| Article | Year |
|---|---|
Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis.
Topics: Adult; Antihypertensive Agents; Bosentan; Boston; Canada; Double-Blind Method; Eisenmenger Complex; Exercise; Female; Heart Septal Defects, Atrial; Heart Septal Defects, Ventricular; Hemodynamics; Humans; Hypertension, Pulmonary; Italy; Male; Middle Aged; Netherlands; Ontario; Oximetry; Pulmonary Circulation; Pulmonary Wedge Pressure; Sulfonamides; Switzerland; Treatment Outcome; United Kingdom; Vascular Resistance | 2010 |
8 other study(ies) available for bosentan anhydrous and Heart Septal Defects, Ventricular
| Article | Year |
|---|---|
A successful cesarean delivery without fetal or maternal morbidity in an Eisenmenger patient with cor triatriatum sinistrum, double-orifice mitral valve, large ventricular septal defect, and single ventricle who was under long-term bosentan treatment.
Topics: Adult; Bosentan; Cardiovascular Agents; Cesarean Section; Cor Triatriatum; Eisenmenger Complex; Female; Heart Septal Defects, Ventricular; Humans; Infant, Extremely Premature; Infant, Newborn; Sulfonamides | 2017 |
Combined approach in ventricular septal defect and adult pulmonary hypertension.
Topics: Administration, Inhalation; Adult; Antihypertensive Agents; Bosentan; Cardiac Surgical Procedures; Drug Therapy, Combination; Female; Heart Septal Defects, Ventricular; Humans; Hypertension, Pulmonary; Nitric Oxide; Piperazines; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Treatment Outcome; Vasodilator Agents | 2013 |
Repair of ventricular septal defect with Eisenmenger syndrome after bosentan treatment.
Topics: Antihypertensive Agents; Bosentan; Cardiac Surgical Procedures; Child; Eisenmenger Complex; Female; Heart Septal Defects, Ventricular; Heart Septum; Humans; Hypertension, Pulmonary; Sulfonamides; Time Factors; Treatment Outcome; Vascular Resistance | 2014 |
Medical treatment for an adult patient with eisenmenger syndrome. A case report.
Topics: Adult; Antihypertensive Agents; Bosentan; Down Syndrome; Eisenmenger Complex; Endothelin Receptor Antagonists; Heart Septal Defects, Ventricular; Humans; Hypertension, Pulmonary; Male; Phenylpropionates; Pyridazines; Sulfonamides | 2015 |
Late complete heart block in an adult patient undergoing percutaneous ventricular septal defect closure.
Topics: Adult; Balloon Occlusion; Bosentan; Cardiac Catheterization; Cardiovascular Agents; Female; Heart Block; Heart Septal Defects, Ventricular; Humans; Risk Factors; Sulfonamides; Time Factors | 2008 |
The management of Eisenmenger syndrome in the modern treatment era: a case report.
Topics: Adult; Antihypertensive Agents; Bosentan; Combined Modality Therapy; Drug Therapy, Combination; Eisenmenger Complex; Exercise Tolerance; Familial Primary Pulmonary Hypertension; Female; Heart Septal Defects, Ventricular; Humans; Hypertension, Pulmonary; Iron, Dietary; Piperazines; Purines; Quality of Life; Sildenafil Citrate; Sulfonamides; Sulfones; Treatment Outcome; Vasodilator Agents | 2011 |
Adult congenital heart disease and pulmonary hypertension: management of a complex case.
Topics: Adult; Antihypertensive Agents; Bosentan; Cardiac Catheterization; Disease Progression; Dyspnea; Eisenmenger Complex; Exercise Test; Follow-Up Studies; Heart Septal Defects, Ventricular; Humans; Hypertension, Pulmonary; Oxygen; Pulmonary Valve Stenosis; Sulfonamides | 2012 |
[An initial experience of endotherine-1 dual-receptor blockade in the treatment of sustained pulmonary hypertension early after congenital cardiac surgery in infancy].
Topics: Antihypertensive Agents; Bosentan; Endothelin A Receptor Antagonists; Female; Heart Septal Defects, Ventricular; Humans; Hypertension, Pulmonary; Infant; Postoperative Complications; Sulfonamides | 2007 |